The results of our association analysis of the clinicopathologic variables of the CRC patients who carried FGFR4 variants showed that being a carrier of the rs1966265 GA genotype was associated with rectal cancer and advanced-stage (stage III) disease. The gene discussed is FGFR4; the disease is rectal cancer.